Literature DB >> 10469057

A switch towards Th2 during serological rebound in children with congenital toxoplasmosis.

S Kahi1, G J Cozon, J M Pinon, T Greenland, M Wallon, M Al Kurdi, J Ferrandiz, F Peyron.   

Abstract

Serological rebounds occur frequently in patients with congenital toxoplasmosis, but remain poorly understood. A link between Th1 and Th2 cytokines and the pathophysiology of infectious diseases has been reported. Production of interferon-gamma (IFN-gamma) and IL-4 in supernatants of whole blood after in vitro specific Toxoplasma gondii stimulation and serum-specific IgE levels were studied in 31 congenitally infected children. IFN-gamma was produced at higher levels by lymphocytes from children with stable congenital toxoplasmosis (n = 18) than from children showing serological rebound (n = 13) (P < 0.04). Conversely, supernatants from children with serological rebound showed higher levels of IL-4 than those from children with stable congenital toxoplasmosis (P < 0.03). The polarized Th2 response was confirmed by a greater (IL-4:IFN-gamma) x 100 ratio (P < 0.0001) and production of T. gondii-specific IgE in six out of 13 children showing serological rebound. These results suggest a role of Th2 cytokines in destabilization of congenital toxoplasmosis and perhaps in local reactivation of the parasite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469057      PMCID: PMC1905379          DOI: 10.1046/j.1365-2249.1999.01019.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets.

Authors:  I Sklenar; T C Jones; S Alkan; P Erb
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

2.  Human T-cell clones against Toxoplasma gondii: production of interferon-gamma, interleukin-2, and strain cross-reactivity.

Authors:  R Saavedra; P Hérion
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  Detection of specific immunoglobulin E in patients with toxoplasmosis.

Authors:  J M Pinon; D Toubas; C Marx; G Mougeot; A Bonnin; A Bonhomme; M Villaume; F Foudrinier; H Lepan
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  In vitro production of interleukin-2 by lymphocytes in whole blood and isolated culture.

Authors:  M Lyte
Journal:  J Clin Lab Immunol       Date:  1988-08

5.  Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity.

Authors:  R E Weir; A R Morgan; W J Britton; C R Butlin; H M Dockrell
Journal:  J Immunol Methods       Date:  1994-11-10       Impact factor: 2.303

6.  Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages.

Authors:  W Bohne; J Heesemann; U Gross
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

7.  A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.

Authors:  S Kahi; G J Cozon; T Greenland; M Wallon; F Gay-Andrieu; F Peyron
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Evaluation of a test system for measuring cytokine production in human whole blood cell cultures.

Authors:  U Elsässer-Beile; S von Kleist; H Gallati
Journal:  J Immunol Methods       Date:  1991-06-03       Impact factor: 2.303

9.  Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis.

Authors:  C A Hunter; C W Roberts; J Alexander
Journal:  Eur J Immunol       Date:  1992-09       Impact factor: 5.532

10.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.

Authors:  J Pène; F Rousset; F Brière; I Chrétien; J Y Bonnefoy; H Spits; T Yokota; N Arai; K Arai; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more
  6 in total

1.  Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.

Authors:  A F Fatoohi; G J N Cozon; T Greenland; J Ferrandiz; J Bienvenu; S Picot; F Peyron
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Authors:  A F Fatoohi; G J N Cozon; M Wallon; S Kahi; F Gay-Andrieu; T Greenland; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-04       Impact factor: 3.267

3.  Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis.

Authors:  Elizabeth Torres-Morales; Laura Taborda; Nestor Cardona; Alejandra De-la-Torre; Juan Carlos Sepulveda-Arias; Manuel Alfonso Patarroyo; Jorge Enrique Gomez-Marin
Journal:  Med Microbiol Immunol       Date:  2014-05-11       Impact factor: 3.402

4.  Spiramycin treatment of Toxoplasma gondii infection in pregnant women impairs the production and the avidity maturation of T. gondii-specific immunoglobulin G antibodies.

Authors:  V Meroni; F Genco; C Tinelli; P Lanzarini; L Bollani; M Stronati; E Petersen
Journal:  Clin Vaccine Immunol       Date:  2009-08-19

5.  Heterogeneity in cellular and humoral immune responses against Toxoplasma gondii antigen in humans.

Authors:  A F Fatoohi; G J N Cozon; P Gonzalo; M Mayencon; T Greenland; S Picot; F Peyron
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

6.  Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis.

Authors:  Fatih Fatoohi; Grégoire Jacques Noël Cozon; Martine Wallon; Laurent Kodjikian; François Peyron
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.